{"gene":"ABHD5","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2006,"finding":"CGI-58/ABHD5 directly interacts with and activates adipose triglyceride lipase (ATGL), stimulating its triacylglycerol hydrolase activity up to 20-fold. CDS-associated point mutations in CGI-58 abolish this ATGL activation. CGI-58/ATGL coexpression attenuates lipid accumulation in COS-7 cells, and antisense RNA-mediated reduction of CGI-58 in 3T3-L1 adipocytes inhibits TG mobilization.","method":"In vitro TG hydrolase assay, Co-IP/interaction studies, gain- and loss-of-function cell models, CDS fibroblast rescue experiments","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1 — reconstituted enzymatic activity in vitro, mutagenesis of disease alleles, multiple orthogonal cell-based assays, independently replicated","pmids":["16679289"],"is_preprint":false},{"year":2001,"finding":"CGI-58 (ABHD5) belongs to the alpha/beta-hydrolase fold family. Its putative catalytic triad contains asparagine instead of the usual serine residue, distinguishing it from classical esterase/lipase/thioesterase subfamily members. Eight distinct loss-of-function mutations in CGI-58 were identified as the genetic cause of Chanarin-Dorfman Syndrome.","method":"Genetic linkage, mutation screening, sequence analysis, bioinformatic domain analysis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational genetic identification in multiple families, replicated extensively; structural inference from sequence","pmids":["11590543"],"is_preprint":false},{"year":2004,"finding":"CGI-58 localizes to lipid droplet surfaces in differentiated 3T3-L1 adipocytes via a direct interaction with perilipin A (PLIN1). This interaction requires the C-terminal sequence of perilipin A (amino acids 382-429). Activation of cAMP-dependent protein kinase (PKA) by isoproterenol disperses CGI-58 from lipid droplets to the cytoplasm, and this shift is reversible.","method":"Proteomic analysis of lipid droplets, CGI-58-GFP live imaging, stable cell lines with perilipin mutants, immunoprecipitation, pharmacological PKA activation/inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (proteomics, imaging, IP, mutagenesis), functionally linked localization","pmids":["15292255"],"is_preprint":false},{"year":2004,"finding":"CGI-58 directly interacts with perilipin via yeast two-hybrid and co-localization studies. CDS-associated missense mutations abolish the ability of CGI-58 to be recruited to lipid droplets and weaken binding to perilipin, establishing that loss of this interaction underlies CDS pathogenesis. CGI-58 also interacts with ADRP (perilipin 2).","method":"Yeast two-hybrid, GFP-CGI-58 overexpression imaging, CDS mutant analysis in 3T3-L1 and CHO-K1 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — yeast two-hybrid plus cell imaging with disease mutant validation","pmids":["15136565"],"is_preprint":false},{"year":2007,"finding":"CGI-58 knockdown causes abnormal lipid droplet accumulation in 3T3-L1 preadipocytes and Hepa1 hepatoma cells, and reduces both basal and PKA-stimulated lipolysis. CGI-58 itself has no intrinsic lipase/esterase activity but enhances ATGL activity. Upon lipolytic stimulation, CGI-58 disperses from lipid droplets to cytosol, and this depends on perilipin phosphorylation which reduces CGI-58 binding.","method":"RNAi knockdown, in vitro lipase activity assay, live-cell imaging, coherent anti-Stokes Raman scattering microscopy","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro activity assay (no intrinsic lipase), RNAi with phenotype, live imaging of localization dynamics","pmids":["17308334"],"is_preprint":false},{"year":2009,"finding":"Perilipin (PLIN1) binds ABHD5 with high affinity, sequestering it and suppressing its interaction with ATGL to reduce basal lipolysis. PKA-mediated phosphorylation of perilipin on Ser492 or Ser517 rapidly releases ABHD5, allowing direct ABHD5–ATGL interaction primarily on lipid droplets containing perilipin.","method":"Bimolecular fluorescence complementation (BiFC) in live cells, FRET imaging, protein trafficking experiments, PKA activation studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — quantitative live-cell protein interaction assays with site-specific mutagenesis of phosphorylation sites","pmids":["19850935"],"is_preprint":false},{"year":2008,"finding":"CGI-58 functions as a coenzyme A-dependent lysophosphatidic acid (LPA) acyltransferase, converting LPA to phosphatidic acid. Recombinant CGI-58 purified from E. coli shows acyl-CoA-dependent acyltransferase activity specifically toward LPA but not other lysophospholipids. This activity is associated with a conserved HXXXXD motif in its C-terminus.","method":"Recombinant protein expression in E. coli, in vitro acyltransferase assay, S. cerevisiae overexpression, intrinsic tryptophan fluorescence quenching, radiolabeled fatty acid incorporation in CDS fibroblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — purified recombinant enzyme with in vitro biochemical assay and functional validation in disease fibroblasts","pmids":["18606822"],"is_preprint":false},{"year":2009,"finding":"Recombinant mouse CGI-58 exhibits CoA-dependent acyltransferase activity specifically for lysophosphatidic acid (not other lysophospholipid acceptors), producing phosphatidic acid. It channels fatty acids released from lipolysis into phospholipids in CDS fibroblasts. The enzyme shows preference for arachidonoyl-CoA and oleoyl-CoA and saturation kinetics.","method":"Recombinant protein from E. coli, in vitro LPA acyltransferase assay with kinetics, radiolabeled fatty acid tracking in CDS fibroblasts","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — purified recombinant enzyme, substrate specificity determined, functional rescue in disease cells","pmids":["19801371"],"is_preprint":false},{"year":2009,"finding":"CGI-58 knockout mice (Cgi-58−/−) display systemic TG accumulation and severe hepatic steatosis, confirming CGI-58's role in ATGL-mediated TG hydrolysis. Additionally, a lethal skin permeability barrier defect independent of ATGL establishes an ATGL-independent function of CGI-58 in epidermal lipid metabolism, linked to impaired acylceramide synthesis.","method":"Global knockout mouse model, lipid analysis, histology, skin barrier assays, lipidomics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with clear dual phenotypic readouts (systemic steatosis + lethal skin barrier defect), establishing two distinct functions","pmids":["20023287"],"is_preprint":false},{"year":2008,"finding":"ABHD5 is located in lipid-transporting lamellar granules of differentiating keratinocytes in the granular epidermal layer. CGI-58 knockdown in cultured keratinocytes reduced expression of differentiation markers, establishing a functional role in keratinocyte differentiation and lamellar granule lipid metabolism.","method":"Immunoelectron microscopy, anti-CGI-58 antibody immunostaining, siRNA knockdown in human keratinocytes, 3D organotypic cultures","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — subcellular localization by immunoelectron microscopy linked to functional consequence via KD","pmids":["18832586"],"is_preprint":false},{"year":2008,"finding":"Mldp (LSDP5/PLIN5) binds ABHD5 and directs it to lipid droplets; this interaction is required for Atgl activation at PLIN5-containing lipid droplets. An ABHD5 mutant (E262K) with greatly reduced Mldp binding cannot prevent lipid droplet accumulation in cells expressing Mldp despite targeting of Atgl.","method":"Protein-protein interaction assays in transfected fibroblasts, cardiac muscle fiber microdissection imaging, ABHD5 E262K mutagenesis, lipid droplet morphology assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis with functional readout, in situ interaction analysis","pmids":["19064991"],"is_preprint":false},{"year":2010,"finding":"The N-terminal region (amino acids 1–30) of CGI-58 contains a tryptophan-rich stretch that is essential for lipid droplet binding and ATGL activation. N-terminally truncated CGI-58 localizes to cytoplasm and fails to activate ATGL, demonstrating that correct LD localization is required for ATGL-activating function.","method":"3D homology modeling, 1H NMR with DPC micelles, GFP-fusion localization in cultured cells, N-terminal deletion mutagenesis, ATGL activation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — NMR structural data plus mutagenesis linked to functional loss of ATGL activation","pmids":["20164531"],"is_preprint":false},{"year":2010,"finding":"G0S2 binds to ATGL independently of CGI-58 and its activity state, and cells co-expressing G0S2 and CGI-58+ATGL cannot stimulate lipid droplet turnover, indicating that CGI-58 and G0S2 regulate ATGL via non-competing mechanisms.","method":"Overexpression studies in cells, Co-IP, lipid droplet morphology assays","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP and cell-based assays, single lab, functional inference","pmids":["20676045"],"is_preprint":false},{"year":2011,"finding":"The C-terminus of PLIN1 sequesters ABHD5 and inhibits basal ATGL activity. Human frame-shift mutations (Leu404fs, Val398fs) in PLIN1 fail to bind ABHD5 as shown by bimolecular fluorescence complementation, leading to constitutive ABHD5-mediated ATGL coactivation and increased basal lipolysis. siRNA knockdown of ABHD5 or ATGL reversed this increased lipolysis.","method":"Bimolecular fluorescence complementation (BiFC), siRNA knockdown of ABHD5/ATGL in stably transfected preadipocytes, lipolysis assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — human disease variant analysis, BiFC protein interaction, epistatic rescue by KD","pmids":["21757733"],"is_preprint":false},{"year":2011,"finding":"The minimal active domain of ATGL (extending to Leu254, beyond the patatin domain to Leu178) can still be activated by CGI-58 and inhibited by G0S2, establishing that the interaction surfaces for both regulators reside within this minimal domain.","method":"Domain truncation mutagenesis, in vitro lipase activity assay, protein-protein interaction studies, 3D homology modeling","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro activity assays with deletion mutants and structural modeling","pmids":["22039468"],"is_preprint":false},{"year":2014,"finding":"CGI-58/ABHD5 Ser239 is phosphorylated by protein kinase A (PKA) in vivo. PKA-mediated phosphorylation of CGI-58 at Ser239 is required for its dispersion from perilipin 1A-coated lipid droplets upon lipolytic stimulation, thereby increasing CGI-58 availability for ATGL coactivation. Phosphorylation does not alter ATGL coactivation activity per se.","method":"Phosphoamino acid analysis, mass spectrometry, immunoblotting of recombinant and endogenous CGI-58, phosphomimetic/alanine mutant localization studies in cells, in vitro ATGL coactivation assay","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1–2 — MS identification of phosphosite, mutagenesis, functional localization assays","pmids":["25421061"],"is_preprint":false},{"year":2015,"finding":"ABHD5 is the direct target of synthetic ligands and endogenous long-chain acyl-CoA ligands that regulate ABHD5–perilipin interactions. Ligand binding to ABHD5 releases it from PLIN1 or PLIN5 without PKA activation, directly activating adipocyte and muscle lipolysis. Affinity probe labeling demonstrated ABHD5 as the direct ligand target.","method":"Molecular imaging, affinity probe labeling, synthetic ligand functional assays in adipocytes and muscle cells, fluorescence complementation","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — direct affinity labeling demonstrating ABHD5 as ligand target, multiple orthogonal functional assays","pmids":["26411340"],"is_preprint":false},{"year":2015,"finding":"NMR structure of the CGI-58 N-terminal tryptophan-rich peptide (residues 10–31) bound to DPC micelles reveals two anchor arms: a left arm (Trp21/Trp25 plus adjacent leucines) and a right arm (Trp29). Simultaneous tryptophan-to-alanine mutations in both arms abolish LD localization and ATGL activation, whereas single-arm mutations do not.","method":"Solution-state NMR structure of LD-anchor peptide in DPC micelles, tryptophan-alanine mutagenesis, subcellular localization assays, ATGL activation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional mutagenesis validation","pmids":["26350461"],"is_preprint":false},{"year":2014,"finding":"Perilipins 2 and 3 lack the C-terminal carboxy-terminal domain of perilipin 1 that binds and stabilizes ABHD5. This C-terminal domain of PLIN1 retards ABHD5 proteasomal degradation. Chimeric PLIN2 or PLIN3 fused with the PLIN1 C-terminus suppress basal lipolysis more effectively by stabilizing ABHD5. Knockdown of PLIN1 in adipocytes reduces ABHD5 expression and LD localization, increasing basal lipolysis.","method":"BiFC, chimeric protein construction, PLIN1 siRNA knockdown, ABHD5 protein stability assays (proteasome inhibition)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including chimeric protein rescue and proteasome experiments","pmids":["24927580"],"is_preprint":false},{"year":2017,"finding":"Two conserved ABHD5 residues (R299 and G328) are specifically required for ATGL lipase activation. Introducing these residues into the ABHD4 paralog (ABHD4 N303R/S332G) conferred ATGL activation ability, and corresponding ABHD5 mutations (R299N, G328S) selectively disrupted lipolysis without affecting ATGL LD translocation or ABHD5 interactions with perilipins/ligands. Structural modeling places these residues on a novel functional surface.","method":"Comparative evolutionary analysis, structural modeling, gain-of-function ABHD4 mutagenesis in Cos7 cells/brown adipocytes/artificial lipid droplets, loss-of-function ABHD5 mutagenesis","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal gain- and loss-of-function mutagenesis with multiple functional readouts","pmids":["28211464"],"is_preprint":false},{"year":2019,"finding":"PNPLA3 (wild-type and 148M variant) directly interacts with CGI-58 and requires CGI-58 for its localization to hepatic lipid droplets. PNPLA3 inhibits ATGL activity by competing for CGI-58, and PNPLA3(148M) promotes hepatic steatosis in a CGI-58-dependent manner. Direct PNPLA3–CGI-58 interaction was demonstrated by Co-IP and pulldown with purified proteins.","method":"Co-IP in mouse liver, in vitro pulldown with purified proteins, liver-specific Cgi-58 KO mice, HuH-7 cell overexpression, hepatic TG measurement","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1–2 — direct interaction confirmed with purified proteins, genetic epistasis in vivo (Cgi-58 KO rescues PNPLA3-148M steatosis)","pmids":["30802989"],"is_preprint":false},{"year":2019,"finding":"ABHD5 functions as a serine protease that cleaves HDAC4 in cardiomyocytes, generating an N-terminal HDAC4 polypeptide (HDAC4-NT). This proteolytic activity inhibits MEF2-dependent gene expression and controls glucose handling in the heart. ABHD5 deficiency leads to loss of HDAC4-NT generation and heart failure, independent of lipid accumulation.","method":"In vitro and in vivo serine protease assay, cardiac-specific gene therapy (HDAC4-NT), transgenic ABHD5 mouse model, pressure-overload heart failure model, analysis of failing human hearts","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — novel enzymatic function demonstrated in vitro and in vivo with rescue experiment, functional dissociation from lipid phenotype","pmids":["31742248"],"is_preprint":false},{"year":2018,"finding":"ABHD5 directly interacts with PNPLA1 and recruits it to lipid droplets, stimulating PNPLA1-mediated esterification of ω-hydroxy ceramides with linoleic acid to produce ω-O-acylceramide (acylceramide). CDS-associated ABHD5 point mutations fail to stimulate PNPLA1-mediated acylceramide biosynthesis.","method":"Acylceramide-producing cell system, immunofluorescence microscopy, ABHD5–PNPLA1 interaction assays, CDS mutant analysis","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 — interaction and functional activation demonstrated with disease mutant validation","pmids":["30361410"],"is_preprint":false},{"year":2018,"finding":"ABHD5 enhances PNPLA1-catalyzed acylceramide production by promoting PNPLA1 localization to lipid droplet membranes. Co-expression of ABHD5 with PNPLA1 transforms dispersed PNPLA1 distribution into lipid droplet-associated localization, and ABHD5 CDS mutations reduce this activity.","method":"Immunofluorescent microscopy, immunoelectron microscopy, cell-based acylceramide production assay, ABHD5 CDS mutant analysis","journal":"Journal of dermatological science","confidence":"High","confidence_rationale":"Tier 2 — mechanistic localization with immunoelectron microscopy and functional readout with disease mutants","pmids":["30527376"],"is_preprint":false},{"year":2016,"finding":"ABHD5 directly competes with CASP3 for binding to cleavage sites of BECN1 (Beclin 1), thereby preventing BECN1 cleavage by CASP3. ABHD5 deficiency allows CASP3-mediated BECN1 cleavage, impairing autophagic flux and promoting genomic instability and tumorigenesis in colorectal cancer, independent of PNPLA2/ATGL.","method":"Co-IP, competition binding assays, autophagic flux assays, ABHD5 KO in CRC cells, clinical tissue correlation","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP and competition binding with functional autophagy readout, single lab","pmids":["27559856"],"is_preprint":false},{"year":2019,"finding":"ABHD5 deficiency in macrophages activates mitochondrial ROS production due to impaired PPARγ signaling, which activates the NLRP3 inflammasome, leading to proinflammatory cytokine secretion. Macrophage-specific CGI-58 KO mice show exacerbated HFD-induced insulin resistance and inflammation reversible by anti-ROS treatment or NLRP3 silencing.","method":"Macrophage-specific CGI-58 KO mice, anti-ROS treatment, NLRP3 siRNA knockdown, co-culture fat slice assay, mitochondrial function assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple mechanistic interventions (ROS scavenging, NLRP3 KD) confirming pathway","pmids":["24703845"],"is_preprint":false},{"year":2014,"finding":"ABHD5 suppresses spermidine synthase (SRM)-dependent spermidine production in macrophages by inhibiting ROS-dependent expression of C/EBPε, a transcription factor that activates srm gene transcription. Macrophage-specific ABHD5 transgene promotes colorectal cancer growth that is prevented by an additional SRM transgene.","method":"In vitro macrophage assays, mouse macrophage-specific transgenic models, SRM transgene rescue experiment, C/EBPε and ROS pathway analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis rescue (SRM transgene prevents ABHD5-transgene-driven tumor growth), pathway mechanistically defined","pmids":["27189574"],"is_preprint":false},{"year":2016,"finding":"ABHD5 deficiency in macrophages promotes NFκB p65-dependent matrix metalloproteinase (MMP) production independently of its triglyceride metabolic function, as neither triglycerides nor ABHD5-regulated metabolites affected cancer cell migration.","method":"Macrophage ABHD5 KO xenograft and genetic cancer models, in vitro migration assays, NFκB pathway analysis, metabolite measurements","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2–3 — functional dissection from metabolic role, NFκB pathway shown, but limited mechanistic depth on how ABHD5 controls NFκB","pmids":["31439546"],"is_preprint":false},{"year":2014,"finding":"Loss of ABHD5 in colon cancer cells induces epithelial-mesenchymal transition by suppressing the AMPKα-p53 pathway, which promotes aerobic glycolysis (Warburg effect). Intestine-specific knockout of Abhd5 in ApcMin/+ mice robustly increases tumorigenesis and malignant transformation.","method":"RNAi silencing, intestine-specific KO in ApcMin/+ mice, AMPK/p53 pathway analysis, Warburg effect measurement","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic model with mechanistic pathway (AMPK-p53) identified and validated","pmids":["25482557"],"is_preprint":false},{"year":2021,"finding":"ABHD5 interacts with DPY30 (core subunit of SET1A methyltransferase complex) in the cytoplasm, inhibiting its nuclear translocation and SET1A-mediated methylation of YAP and histone H3. ABHD5 loss allows DPY30 nuclear accumulation, promoting YAP transcriptional activity and c-Met-driven cancer stemness.","method":"Co-IP, subcellular fractionation, DPY30 localization imaging, SET1A activity assays, ChIP, CRC cell functional assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — direct interaction demonstrated, nuclear translocation mechanistically linked to epigenetic and transcriptional consequences","pmids":["34795238"],"is_preprint":false},{"year":2012,"finding":"CGI-58 functions as a lysophosphatidylglycerol acyltransferase, catalyzing reacylation of lysophosphatidylglycerol to phosphatidylglycerol (PG) in an acyl-CoA-dependent manner. Overexpression and knockdown of CGI-58 adversely affect endogenous PG levels in C2C12 cells, and CGI-58 regulates autophagy/mitophagy through effects on cardiolipin synthesis.","method":"Recombinant CGI-58 from Sf9 insect cells and mammalian cells, in vitro acyltransferase assay, PG measurement, autophagy/mitophagy assays in C2C12 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–3 — in vitro enzymatic activity shown with purified protein, cellular functional readouts; conflicting with LPA acyltransferase specificity in prior studies","pmids":["25315780"],"is_preprint":false},{"year":2020,"finding":"ABHD5 cooperates specifically with ATGL (not ABHD4) to mobilize lipid droplet triglycerides for hepatitis C virus assembly. ABHD5 residues critical for ATGL activation are required for pro-viral lipolytic function. Grafting these ABHD5 residues onto ABHD4 restored ATGL interaction and pro-viral function; mutating the predicted ABHD5-ATGL interface ablated both lipolysis and HCV assembly support.","method":"ABHD4/ABHD5 chimeric mutagenesis, protein interaction assays, lipid droplet lipolysis assays, HCV production assays, ATGL KD/modulation","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 1–2 — gain/loss-of-function chimeric protein approach with multiple functional readouts, mechanistically defines interaction interface","pmids":["32542055"],"is_preprint":false},{"year":2019,"finding":"Lipid droplet targeting of ABHD5 and PNPLA3 I148M is required for their direct interaction. PNPLA3 I148M has greater association with ABHD5 than WT PNPLA3 (by fluorescence cross-correlation spectroscopy), and the C-terminus of PNPLA3 is sufficient for LD targeting and ABHD5 interaction. PNPLA3 I148M LD targeting is required to promote steatosis in vitro and in liver.","method":"Fluorescence cross-correlation spectroscopy (FCCS), molecular modeling, C-terminal domain truncation/chimeric proteins, in vitro steatosis assay, in vivo liver steatosis model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — quantitative in-cell FCCS protein interaction, mutagenesis, and in vivo functional validation","pmids":["39814233"],"is_preprint":false},{"year":2020,"finding":"ABHD5-mediated lipolysis inhibits mTORC1 signaling in prostate cancer cells by elevating intracellular AMP content and activating AMPK. This creates an energy-consuming futile cycle between TG hydrolysis and resynthesis (requiring DGAT1/DGAT2), leading to AMPK activation, mTORC1 inhibition, and cancer cell growth arrest.","method":"ABHD5 overexpression and pharmacological lipolysis activation, transcriptomic profiling, AMPK/mTORC1 pathway analysis, DGAT1/2 inhibition, AMP measurement","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pathway interventions supporting mechanism, single lab","pmids":["33219129"],"is_preprint":false},{"year":2016,"finding":"ABHD5 associates with hepatic lipid droplets and is required for HCV-driven lipid droplet consumption; Chanarin-Dorfman syndrome ABHD5 mutants are mislocalized and unable to support HCV production or LD lipolysis. A novel tribasic motif in ABHD5 determines both lipolytic and pro-viral properties without affecting LD localization.","method":"siRNA screen, ABHD5 mutant localization studies, lipid droplet hydrolysis assays, HCV assembly/release assays, tribasic motif mutagenesis","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 — systematic mutagenesis with multiple functional readouts, disease mutant validation","pmids":["27124600"],"is_preprint":false},{"year":2013,"finding":"CGI-58 knockdown sequesters diacylglycerols (DAG) in lipid droplets/ER rather than the plasma membrane, preventing PKCε translocation to the plasma membrane and thereby protecting against DAG-mediated hepatic insulin resistance despite hepatic steatosis.","method":"Antisense oligonucleotide KD, hyperinsulinemic-euglycemic clamp, subcellular DAG fractionation, PKCε localization analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vivo clamp studies with subcellular fractionation mechanistically linking DAG compartmentalization to PKCε and insulin resistance","pmids":["23302688"],"is_preprint":false},{"year":2019,"finding":"ATGL/CGI-58 are expressed in intestinal enterocytes and are critical for hydrolysis of a specific lipid droplet pool derived from basolateral (blood) lipid re-uptake, but not for chylomicron synthesis from dietary lipids. Intestine-specific ATGL/CGI-58 double KO mice show massive cLD accumulation independent of dietary lipids.","method":"Intestine-specific double KO mouse model, dietary lipid absorption assays, lipid droplet pool characterization","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic double KO with defined physiological readout establishing specific LD pool assignment","pmids":["31412256"],"is_preprint":false},{"year":2016,"finding":"CGI-58 regulates hepatic TG metabolism and diacylglycerol levels in an ATGL-independent manner; CGI-58 knockdown causes hepatic steatosis in the genetic absence of ATGL. CGI-58 also regulates hepatic inflammation independently of ATGL.","method":"Direct comparison of single vs. double CGI-58/ATGL knockdown mice (ASO), hepatic lipid and inflammation measurements","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vivo (KO/KD comparison) establishing ATGL-independent hepatic function","pmids":["27396333"],"is_preprint":false},{"year":2010,"finding":"A murine CGI-58 short splicing isoform (mCGI-58S), lacking exons 2 and 3, localizes to cytoplasm (not LDs), cannot activate ATGL, but retains lysophosphatidic acid acyltransferase activity. This establishes functional dissociation between LD/ATGL activation and LPA acyltransferase activities.","method":"cDNA cloning, GFP-fusion localization, ATGL activation assay, LPA acyltransferase assay, LD turnover assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis/isoform comparison with multiple functional assays, single lab","pmids":["20083112"],"is_preprint":false}],"current_model":"ABHD5/CGI-58 is a lipid droplet-associated co-activator protein (lacking intrinsic lipase activity) that stimulates ATGL-mediated triacylglycerol hydrolysis up to 20-fold via direct protein–protein interaction; its activity is regulated by sequestration on lipid droplets through high-affinity binding to perilipin proteins (PLIN1, PLIN5), which is relieved by PKA-mediated phosphorylation of both perilipin and ABHD5-Ser239 upon adrenergic stimulation; beyond ATGL coactivation, ABHD5 also acts as an LPA acyltransferase, a coactivator of PNPLA1 for acylceramide biosynthesis (critical for skin barrier), a serine protease cleaving HDAC4 (cardioprotective), a direct PNPLA3-I148M interaction partner sequestering ABHD5 on hepatic lipid droplets to promote steatosis, a competitor of CASP3 for BECN1 cleavage sites (regulating autophagy), and an inhibitor of DPY30/SET1A nuclear methyltransferase activity (regulating cancer stemness), collectively establishing ABHD5 as a multifunctional lipid droplet scaffold protein that coordinates lipolysis, lipid signaling, epidermal barrier formation, cardiac glucose metabolism, and inflammatory signaling across multiple tissues."},"narrative":{"teleology":[{"year":2001,"claim":"Identifying ABHD5 as the gene mutated in Chanarin–Dorfman syndrome established that this α/β-hydrolase-fold protein with an atypical catalytic triad (Asn replacing Ser) is essential for neutral lipid metabolism in humans.","evidence":"Genetic linkage and mutation screening in CDS families combined with bioinformatic domain analysis","pmids":["11590543"],"confidence":"High","gaps":["No enzymatic or coactivator function yet demonstrated","Mechanistic basis of lipid accumulation unknown"]},{"year":2004,"claim":"Demonstrating that ABHD5 localizes to lipid droplets via direct binding to perilipin 1's C-terminus and is released upon PKA activation established the regulated-sequestration model for ABHD5 availability.","evidence":"Lipid droplet proteomics, GFP-CGI-58 live imaging, yeast two-hybrid, perilipin mutant analysis in 3T3-L1 adipocytes","pmids":["15292255","15136565"],"confidence":"High","gaps":["Target enzyme for ABHD5 coactivation not yet identified","Mechanism of PKA-mediated release not molecularly defined"]},{"year":2006,"claim":"The discovery that ABHD5 directly binds and activates ATGL up to 20-fold—and that CDS mutations abolish this activation—identified the central enzymatic target and mechanistically explained systemic triglyceride accumulation in CDS.","evidence":"In vitro TG hydrolase assay with recombinant proteins, Co-IP, gain/loss-of-function in COS-7 and 3T3-L1 cells, CDS fibroblast rescue","pmids":["16679289"],"confidence":"High","gaps":["Interaction surface between ABHD5 and ATGL undefined","ATGL-independent functions not addressed"]},{"year":2008,"claim":"Identification of intrinsic LPA acyltransferase activity in purified recombinant ABHD5 revealed that the protein possesses its own catalytic function beyond ATGL coactivation, converting LPA to phosphatidic acid via a conserved HXXXXD motif.","evidence":"Recombinant ABHD5 from E. coli, in vitro acyltransferase assay with substrate specificity, radiolabeled fatty acid incorporation in CDS fibroblasts","pmids":["18606822","19801371"],"confidence":"High","gaps":["Physiological significance of LPA acyltransferase activity in vivo not established","Relationship between acyltransferase and ATGL-coactivation functions unclear"]},{"year":2009,"claim":"The CGI-58 knockout mouse revealed two separable functions: systemic TG accumulation (ATGL-dependent) and a lethal skin barrier defect from impaired acylceramide synthesis (ATGL-independent), establishing ABHD5 as a bifunctional protein.","evidence":"Global Cgi-58 knockout mouse with lipid analysis, histology, and skin barrier assays","pmids":["20023287"],"confidence":"High","gaps":["Molecular partner mediating acylceramide synthesis unknown at this stage","Relative contributions of ATGL activation vs. acyltransferase activity to each phenotype unclear"]},{"year":2009,"claim":"Quantitative live-cell BiFC and FRET resolved the sequential mechanism: PLIN1 sequesters ABHD5 under basal conditions, and PKA phosphorylation of specific perilipin serines (Ser492/Ser517) releases ABHD5 to interact with ATGL on lipid droplets.","evidence":"BiFC and FRET imaging in live cells with perilipin phosphosite mutants, PKA activation","pmids":["19850935"],"confidence":"High","gaps":["Whether ABHD5 itself is phosphorylated during this process was not yet known","Stoichiometry of the ABHD5–PLIN1–ATGL complex undefined"]},{"year":2010,"claim":"NMR and mutagenesis of the N-terminal tryptophan-rich region (residues 10–31) showed that two amphipathic anchor arms mediate lipid droplet binding, which is prerequisite for ATGL activation—functionally separating LD targeting from catalytic domains.","evidence":"Solution NMR in DPC micelles, tryptophan-to-alanine mutagenesis, subcellular localization and ATGL activation assays","pmids":["20164531","26350461"],"confidence":"High","gaps":["Full-length ABHD5 structure unavailable","How the N-terminal anchor cooperates with perilipin binding unclear"]},{"year":2014,"claim":"Identification of PKA phosphorylation at ABHD5-Ser239 showed that ABHD5 itself is directly regulated post-translationally: phosphorylation promotes its dispersion from PLIN1-coated droplets without altering intrinsic ATGL coactivation capacity.","evidence":"Mass spectrometry, phosphomimetic/alanine mutant localization studies, in vitro ATGL coactivation assay","pmids":["25421061"],"confidence":"High","gaps":["Other phosphorylation sites or post-translational modifications not systematically surveyed","Kinetic relationship between perilipin and ABHD5 phosphorylation events unresolved"]},{"year":2014,"claim":"PLIN1's C-terminal domain was shown to stabilize ABHD5 against proteasomal degradation, explaining why perilipins 2 and 3 cannot fully substitute for PLIN1 in restraining basal lipolysis—and why PLIN1 frameshift mutations cause constitutive lipolysis.","evidence":"BiFC, chimeric perilipin constructs, PLIN1 siRNA, proteasome inhibition assays, PLIN1 frameshift mutation analysis","pmids":["24927580","21757733"],"confidence":"High","gaps":["Structural basis of PLIN1 C-terminus–ABHD5 interaction unknown","Whether ABHD5 degradation differs across tissues not examined"]},{"year":2015,"claim":"Discovery that endogenous long-chain acyl-CoAs and synthetic ligands directly bind ABHD5 and release it from perilipins without PKA activation revealed a second, hormone-independent mechanism for controlling lipolysis.","evidence":"Affinity probe labeling of ABHD5, synthetic ligand functional assays in adipocytes and muscle cells, fluorescence complementation","pmids":["26411340"],"confidence":"High","gaps":["Binding site on ABHD5 for acyl-CoA ligands not structurally defined","Physiological contexts where ligand-driven (vs. PKA-driven) release dominates remain unclear"]},{"year":2017,"claim":"Reciprocal gain- and loss-of-function mutagenesis identified R299 and G328 as the two residues that specifically confer ATGL coactivation, defining a discrete functional surface distinct from LD targeting and perilipin/ligand-binding regions.","evidence":"ABHD4→ABHD5 chimeric mutagenesis in Cos7 cells, brown adipocytes, and artificial lipid droplets with multiple readouts","pmids":["28211464"],"confidence":"High","gaps":["Direct structural visualization of the ABHD5–ATGL interface lacking","Whether these residues participate in activation of other PNPLA family members untested"]},{"year":2018,"claim":"Demonstrating that ABHD5 recruits PNPLA1 to lipid droplets and stimulates its ω-O-acylceramide biosynthesis—abolished by CDS mutations—identified the molecular mechanism underlying the ATGL-independent skin barrier defect observed in CGI-58 knockout mice.","evidence":"Immunofluorescence, immunoelectron microscopy, cell-based acylceramide production assays, CDS mutant analysis","pmids":["30361410","30527376"],"confidence":"High","gaps":["Whether ABHD5 allosterically activates PNPLA1 or only promotes its LD recruitment is unresolved","Therapeutic rescue of CDS skin phenotype by PNPLA1 modulation not tested"]},{"year":2019,"claim":"Discovery that PNPLA3 (especially the I148M steatosis variant) directly binds and sequesters ABHD5 on hepatic lipid droplets—competing with ATGL for ABHD5—mechanistically explained how PNPLA3-I148M promotes hepatic steatosis through ABHD5 titration.","evidence":"Co-IP in liver, in vitro pulldown with purified proteins, liver-specific Cgi-58 KO epistasis, FCCS quantification of binding affinities, domain mapping","pmids":["30802989","39814233"],"confidence":"High","gaps":["Structural basis of differential PNPLA3 WT vs. I148M affinity for ABHD5 unknown","Whether therapeutic ABHD5 ligands can overcome PNPLA3-I148M sequestration untested"]},{"year":2019,"claim":"Identification of ABHD5 as a serine protease that cleaves HDAC4 in cardiomyocytes—generating a cardioprotective N-terminal fragment that inhibits MEF2-dependent transcription—revealed an entirely new enzymatic activity independent of lipid metabolism.","evidence":"In vitro and in vivo protease assays, cardiac-specific gene therapy rescue, pressure-overload heart failure model, analysis of failing human hearts","pmids":["31742248"],"confidence":"High","gaps":["Catalytic mechanism and active site for protease activity not structurally characterized","Whether other substrates beyond HDAC4 are cleaved unknown","Independent replication of protease activity awaited"]},{"year":2016,"claim":"ABHD5 was shown to protect BECN1 from CASP3-mediated cleavage by directly competing for the cleavage site, maintaining autophagic flux—loss of ABHD5 impairs autophagy and promotes colorectal tumorigenesis independently of ATGL.","evidence":"Co-IP, competition binding assays, autophagic flux assays, ABHD5 KO in CRC cells","pmids":["27559856"],"confidence":"Medium","gaps":["Structural basis of ABHD5–BECN1 interaction undefined","Single-lab finding not yet independently confirmed","Whether ABHD5 protease activity contributes to BECN1 protection untested"]},{"year":2016,"claim":"Establishing that CGI-58 regulates hepatic TG and DAG levels independently of ATGL (by comparing single vs. double KD mice) showed that ABHD5 has ATGL-independent lipid metabolic functions in liver, possibly through its acyltransferase activity or activation of other PNPLA enzymes.","evidence":"Direct comparison of single vs. double CGI-58/ATGL knockdown mice by ASO, hepatic lipid and inflammation measurements","pmids":["27396333"],"confidence":"High","gaps":["Precise enzyme(s) mediating ATGL-independent hepatic TG hydrolysis not identified","Contribution of LPA acyltransferase vs. other activities unclear"]},{"year":2021,"claim":"Discovery that ABHD5 binds DPY30 in the cytoplasm and prevents its nuclear translocation—thereby inhibiting SET1A-mediated methylation of YAP and histone H3—linked ABHD5 to epigenetic regulation and cancer stemness control.","evidence":"Co-IP, subcellular fractionation, DPY30 localization imaging, SET1A activity assays, ChIP, CRC cell functional assays","pmids":["34795238"],"confidence":"High","gaps":["Binding interface between ABHD5 and DPY30 not structurally characterized","Whether this mechanism operates in normal (non-cancer) tissues unknown","Relationship between DPY30 sequestration and ABHD5's lipid droplet functions not explored"]},{"year":null,"claim":"A full-length atomic structure of ABHD5 is lacking, leaving the spatial relationships among the N-terminal LD anchor, the ATGL-activating surface (R299/G328), the acyltransferase HXXXXD motif, the ligand-binding pocket, the perilipin-binding region, and the putative protease active site unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of full-length ABHD5","How a single protein accommodates ATGL coactivation, LPA acyltransferase, and serine protease activities structurally unresolved","Comprehensive substrate profiling for the protease activity needed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[6,7,30,38]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,5,13,19]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[11,16,17]}],"localization":[{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[2,3,4,9,11,17,34]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,15,38]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,5,6,7,8,15,16,19,35,36,37]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[25,28,29,33]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[24,30]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[29]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[25,26]}],"complexes":[],"partners":["PNPLA2","PLIN1","PLIN5","PNPLA1","PNPLA3","HDAC4","DPY30","BECN1"],"other_free_text":[]},"mechanistic_narrative":"ABHD5 (CGI-58) is a multifunctional lipid droplet scaffold protein that coordinates triacylglycerol hydrolysis, phospholipid remodeling, epidermal barrier formation, and signaling across adipose, hepatic, cardiac, and immune tissues. ABHD5 lacks intrinsic lipase activity due to an asparagine substitution in its catalytic triad but activates ATGL-mediated triacylglycerol hydrolysis up to 20-fold through direct protein–protein interaction requiring residues R299 and G328; its availability is governed by sequestration on lipid droplets via high-affinity binding to perilipin 1 (C-terminal domain) and PLIN5, which is relieved by PKA-mediated phosphorylation of both perilipin and ABHD5-Ser239 or by direct binding of long-chain acyl-CoA ligands [PMID:16679289, PMID:19850935, PMID:25421061, PMID:26411340, PMID:28211464]. Beyond ATGL coactivation, ABHD5 possesses intrinsic lysophosphatidic acid acyltransferase activity, coactivates PNPLA1 for acylceramide biosynthesis essential for the epidermal permeability barrier, acts as a serine protease cleaving HDAC4 to regulate cardiac glucose metabolism, sequesters PNPLA3-I148M on hepatic lipid droplets to promote steatosis, protects BECN1 from CASP3 cleavage to maintain autophagic flux, and retains DPY30 in the cytoplasm to inhibit SET1A-mediated histone methylation [PMID:18606822, PMID:30361410, PMID:31742248, PMID:30802989, PMID:27559856, PMID:34795238]. Loss-of-function mutations in ABHD5 cause Chanarin–Dorfman syndrome, characterized by systemic triglyceride accumulation, ichthyosis from defective acylceramide synthesis, and hepatic steatosis [PMID:11590543, PMID:20023287]."},"prefetch_data":{"uniprot":{"accession":"Q8WTS1","full_name":"1-acylglycerol-3-phosphate O-acyltransferase ABHD5","aliases":["Abhydrolase domain-containing protein 5","Lipid droplet-binding protein CGI-58"],"length_aa":349,"mass_kda":39.1,"function":"Coenzyme A-dependent lysophosphatidic acid acyltransferase that catalyzes the transfer of an acyl group on a lysophosphatidic acid (PubMed:18606822). Functions preferentially with 1-oleoyl-lysophosphatidic acid followed by 1-palmitoyl-lysophosphatidic acid, 1-stearoyl-lysophosphatidic acid and 1-arachidonoyl-lysophosphatidic acid as lipid acceptor. Functions preferentially with arachidonoyl-CoA followed by oleoyl-CoA as acyl group donors (By similarity). Functions in phosphatidic acid biosynthesis (PubMed:18606822). May regulate the cellular storage of triacylglycerol through activation of the phospholipase PNPLA2 (PubMed:16679289). Involved in keratinocyte differentiation (PubMed:18832586). Regulates lipid droplet fusion (By similarity)","subcellular_location":"Cytoplasm; Lipid droplet; Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q8WTS1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABHD5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ABHD5","total_profiled":1310},"omim":[{"mim_id":"619728","title":"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 4, N-ACYL PHOSPHOLIPASE B; ABHD4","url":"https://www.omim.org/entry/619728"},{"mim_id":"616966","title":"ABHYDROLASE DOMAIN-CONTAINING PROTEIN 6, ACYLGLYCEROL LIPASE; ABHD6","url":"https://www.omim.org/entry/616966"},{"mim_id":"613877","title":"LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4","url":"https://www.omim.org/entry/613877"},{"mim_id":"613248","title":"PERILIPIN 5; PLIN5","url":"https://www.omim.org/entry/613248"},{"mim_id":"610717","title":"NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM","url":"https://www.omim.org/entry/610717"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ABHD5"},"hgnc":{"alias_symbol":["CGI-58","NCIE2"],"prev_symbol":[]},"alphafold":{"accession":"Q8WTS1","domains":[{"cath_id":"3.40.50.1820","chopping":"29-183_192-346","consensus_level":"high","plddt":92.3148,"start":29,"end":346}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WTS1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WTS1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WTS1-F1-predicted_aligned_error_v6.png","plddt_mean":87.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABHD5","jax_strain_url":"https://www.jax.org/strain/search?query=ABHD5"},"sequence":{"accession":"Q8WTS1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WTS1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WTS1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WTS1"}},"corpus_meta":[{"pmid":"16679289","id":"PMC_16679289","title":"Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome.","date":"2006","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16679289","citation_count":738,"is_preprint":false},{"pmid":"11590543","id":"PMC_11590543","title":"Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11590543","citation_count":379,"is_preprint":false},{"pmid":"19850935","id":"PMC_19850935","title":"Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl).","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19850935","citation_count":312,"is_preprint":false},{"pmid":"15292255","id":"PMC_15292255","title":"Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15292255","citation_count":256,"is_preprint":false},{"pmid":"19401457","id":"PMC_19401457","title":"Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.","date":"2009","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19401457","citation_count":238,"is_preprint":false},{"pmid":"15136565","id":"PMC_15136565","title":"CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15136565","citation_count":215,"is_preprint":false},{"pmid":"30802989","id":"PMC_30802989","title":"PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.","date":"2019","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/30802989","citation_count":179,"is_preprint":false},{"pmid":"20023287","id":"PMC_20023287","title":"Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58).","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20023287","citation_count":157,"is_preprint":false},{"pmid":"17308334","id":"PMC_17308334","title":"CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation.","date":"2007","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/17308334","citation_count":136,"is_preprint":false},{"pmid":"20802159","id":"PMC_20802159","title":"CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20802159","citation_count":133,"is_preprint":false},{"pmid":"23302688","id":"PMC_23302688","title":"CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23302688","citation_count":133,"is_preprint":false},{"pmid":"19064991","id":"PMC_19064991","title":"Functional interactions between Mldp (LSDP5) and Abhd5 in the control of intracellular lipid accumulation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19064991","citation_count":122,"is_preprint":false},{"pmid":"18606822","id":"PMC_18606822","title":"CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18606822","citation_count":111,"is_preprint":false},{"pmid":"26411340","id":"PMC_26411340","title":"Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle.","date":"2015","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26411340","citation_count":101,"is_preprint":false},{"pmid":"20876112","id":"PMC_20876112","title":"Disruption of the Arabidopsis CGI-58 homologue produces Chanarin-Dorfman-like lipid droplet accumulation in plants.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20876112","citation_count":99,"is_preprint":false},{"pmid":"20164531","id":"PMC_20164531","title":"The N-terminal region of comparative gene identification-58 (CGI-58) is important for lipid droplet binding and activation of adipose triglyceride lipase.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20164531","citation_count":98,"is_preprint":false},{"pmid":"20676045","id":"PMC_20676045","title":"Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20676045","citation_count":95,"is_preprint":false},{"pmid":"25482557","id":"PMC_25482557","title":"Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25482557","citation_count":86,"is_preprint":false},{"pmid":"24703845","id":"PMC_24703845","title":"Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24703845","citation_count":84,"is_preprint":false},{"pmid":"27189574","id":"PMC_27189574","title":"Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27189574","citation_count":82,"is_preprint":false},{"pmid":"19801371","id":"PMC_19801371","title":"CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase.","date":"2009","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/19801371","citation_count":80,"is_preprint":false},{"pmid":"22039468","id":"PMC_22039468","title":"The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22039468","citation_count":77,"is_preprint":false},{"pmid":"21757733","id":"PMC_21757733","title":"Human frame shift mutations affecting the carboxyl terminus of perilipin increase lipolysis by failing to sequester the adipose triglyceride lipase (ATGL) coactivator AB-hydrolase-containing 5 (ABHD5).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21757733","citation_count":76,"is_preprint":false},{"pmid":"23408028","id":"PMC_23408028","title":"Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and following stimulated contraction.","date":"2013","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23408028","citation_count":76,"is_preprint":false},{"pmid":"14708602","id":"PMC_14708602","title":"Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome.","date":"2003","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/14708602","citation_count":74,"is_preprint":false},{"pmid":"23667126","id":"PMC_23667126","title":"The α/β hydrolase CGI-58 and peroxisomal transport protein PXA1 coregulate lipid homeostasis and signaling in Arabidopsis.","date":"2013","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/23667126","citation_count":69,"is_preprint":false},{"pmid":"25421061","id":"PMC_25421061","title":"CGI-58/ABHD5 is phosphorylated on Ser239 by protein kinase A: control of subcellular localization.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25421061","citation_count":67,"is_preprint":false},{"pmid":"19061969","id":"PMC_19061969","title":"Chanarin-Dorfman syndrome: deficiency in CGI-58, a lipid droplet-bound coactivator of lipase.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19061969","citation_count":60,"is_preprint":false},{"pmid":"27559856","id":"PMC_27559856","title":"ABHD5 interacts with BECN1 to regulate autophagy and tumorigenesis of colon cancer independent of PNPLA2.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/27559856","citation_count":58,"is_preprint":false},{"pmid":"28877685","id":"PMC_28877685","title":"Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.","date":"2017","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28877685","citation_count":58,"is_preprint":false},{"pmid":"24927580","id":"PMC_24927580","title":"Perilipins 2 and 3 lack a carboxy-terminal domain present in perilipin 1 involved in sequestering ABHD5 and suppressing basal lipolysis.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24927580","citation_count":56,"is_preprint":false},{"pmid":"31742248","id":"PMC_31742248","title":"The lipid droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4.","date":"2019","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31742248","citation_count":55,"is_preprint":false},{"pmid":"34795238","id":"PMC_34795238","title":"ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34795238","citation_count":53,"is_preprint":false},{"pmid":"31439546","id":"PMC_31439546","title":"Macrophage ABHD5 Suppresses NFκB-Dependent Matrix Metalloproteinase Expression and Cancer Metastasis.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31439546","citation_count":50,"is_preprint":false},{"pmid":"17664529","id":"PMC_17664529","title":"CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cells.","date":"2007","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/17664529","citation_count":49,"is_preprint":false},{"pmid":"21122093","id":"PMC_21122093","title":"Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene.","date":"2010","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21122093","citation_count":48,"is_preprint":false},{"pmid":"30954460","id":"PMC_30954460","title":"Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations.","date":"2019","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/30954460","citation_count":47,"is_preprint":false},{"pmid":"26350461","id":"PMC_26350461","title":"Structure of a CGI-58 motif provides the molecular basis of lipid droplet anchoring.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26350461","citation_count":46,"is_preprint":false},{"pmid":"30527376","id":"PMC_30527376","title":"Molecular mechanism of the ichthyosis pathology of Chanarin-Dorfman syndrome: Stimulation of PNPLA1-catalyzed ω-O-acylceramide production by ABHD5.","date":"2018","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/30527376","citation_count":45,"is_preprint":false},{"pmid":"30361410","id":"PMC_30361410","title":"ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier.","date":"2018","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/30361410","citation_count":45,"is_preprint":false},{"pmid":"22383684","id":"PMC_22383684","title":"Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58.","date":"2012","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/22383684","citation_count":44,"is_preprint":false},{"pmid":"28211464","id":"PMC_28211464","title":"Molecular Basis of ABHD5 Lipolysis Activation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28211464","citation_count":42,"is_preprint":false},{"pmid":"22228714","id":"PMC_22228714","title":"CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin action.","date":"2012","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22228714","citation_count":42,"is_preprint":false},{"pmid":"27396333","id":"PMC_27396333","title":"Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activation.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27396333","citation_count":39,"is_preprint":false},{"pmid":"26330055","id":"PMC_26330055","title":"ATGL and CGI-58 are lipid droplet proteins of the hepatic stellate cell line HSC-T6.","date":"2015","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/26330055","citation_count":36,"is_preprint":false},{"pmid":"29026202","id":"PMC_29026202","title":"Loss of ABHD5 promotes the aggressiveness of prostate cancer cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29026202","citation_count":35,"is_preprint":false},{"pmid":"32542055","id":"PMC_32542055","title":"The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly.","date":"2020","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/32542055","citation_count":35,"is_preprint":false},{"pmid":"15127008","id":"PMC_15127008","title":"Steatohepatitis and unsuspected micronodular cirrhosis in Dorfman-Chanarin syndrome with documented ABHD5 mutation.","date":"2004","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/15127008","citation_count":35,"is_preprint":false},{"pmid":"20190389","id":"PMC_20190389","title":"Crucial role of CGI-58/alpha/beta hydrolase domain-containing protein 5 in lipid metabolism.","date":"2010","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/20190389","citation_count":30,"is_preprint":false},{"pmid":"25315780","id":"PMC_25315780","title":"Comparative gene identification-58 (CGI-58) promotes autophagy as a putative lysophosphatidylglycerol acyltransferase.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25315780","citation_count":30,"is_preprint":false},{"pmid":"31412256","id":"PMC_31412256","title":"ATGL/CGI-58-Dependent Hydrolysis of a Lipid Storage Pool in Murine Enterocytes.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31412256","citation_count":29,"is_preprint":false},{"pmid":"23145367","id":"PMC_23145367","title":"Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling.","date":"2012","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/23145367","citation_count":29,"is_preprint":false},{"pmid":"27124600","id":"PMC_27124600","title":"ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production.","date":"2016","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/27124600","citation_count":27,"is_preprint":false},{"pmid":"25316883","id":"PMC_25316883","title":"Deletion of CGI-58 or adipose triglyceride lipase differently affects macrophage function and atherosclerosis.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25316883","citation_count":27,"is_preprint":false},{"pmid":"19211039","id":"PMC_19211039","title":"ABHD5/CGI-58 facilitates the assembly and secretion of apolipoprotein B lipoproteins by McA RH7777 rat hepatoma cells.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19211039","citation_count":27,"is_preprint":false},{"pmid":"25381252","id":"PMC_25381252","title":"The hepatitis C virus core protein inhibits adipose triglyceride lipase (ATGL)-mediated lipid mobilization and enhances the ATGL interaction with comparative gene identification 58 (CGI-58) and lipid droplets.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25381252","citation_count":27,"is_preprint":false},{"pmid":"24618586","id":"PMC_24618586","title":"Intestinal Cgi-58 deficiency reduces postprandial lipid absorption.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24618586","citation_count":26,"is_preprint":false},{"pmid":"32170127","id":"PMC_32170127","title":"Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32170127","citation_count":25,"is_preprint":false},{"pmid":"25431838","id":"PMC_25431838","title":"Macrophage CGI-58 deficiency promotes IL-1β transcription by activating the SOCS3-FOXO1 pathway.","date":"2015","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/25431838","citation_count":24,"is_preprint":false},{"pmid":"28928121","id":"PMC_28928121","title":"Novel Pharmacological Probes Reveal ABHD5 as a Locus of Lipolysis Control in White and Brown Adipocytes.","date":"2017","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28928121","citation_count":24,"is_preprint":false},{"pmid":"18832586","id":"PMC_18832586","title":"CGI-58 is an alpha/beta-hydrolase within lipid transporting lamellar granules of differentiated keratinocytes.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18832586","citation_count":24,"is_preprint":false},{"pmid":"18644654","id":"PMC_18644654","title":"Severe steatohepatitis in a patient with a rare neutral lipid storage disorder due to ABHD5 mutation.","date":"2008","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/18644654","citation_count":24,"is_preprint":false},{"pmid":"33219129","id":"PMC_33219129","title":"ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33219129","citation_count":23,"is_preprint":false},{"pmid":"32705602","id":"PMC_32705602","title":"CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.","date":"2020","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/32705602","citation_count":23,"is_preprint":false},{"pmid":"36355098","id":"PMC_36355098","title":"ABHD5-A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions.","date":"2022","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/36355098","citation_count":22,"is_preprint":false},{"pmid":"23557589","id":"PMC_23557589","title":"Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.","date":"2013","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23557589","citation_count":21,"is_preprint":false},{"pmid":"35173175","id":"PMC_35173175","title":"Structural and functional insights into ABHD5, a ligand-regulated lipase co-activator.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35173175","citation_count":20,"is_preprint":false},{"pmid":"24628803","id":"PMC_24628803","title":"Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.","date":"2014","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24628803","citation_count":20,"is_preprint":false},{"pmid":"30583026","id":"PMC_30583026","title":"Molecular characterization of ABHD5 gene promoter in intramuscular preadipocytes of Qinchuan cattle: Roles of Evi1 and C/EBPα.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30583026","citation_count":19,"is_preprint":false},{"pmid":"20307695","id":"PMC_20307695","title":"Molecular analysis of Chanarin-Dorfman syndrome (CDS) patients: Identification of novel mutations in the ABHD5 gene.","date":"2010","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20307695","citation_count":19,"is_preprint":false},{"pmid":"21885429","id":"PMC_21885429","title":"Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity.","date":"2011","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/21885429","citation_count":19,"is_preprint":false},{"pmid":"22373837","id":"PMC_22373837","title":"Novel nonsense mutation of ABHD5 in Dorfman-Chanarin syndrome with unusual findings: a challenge for genotype-phenotype correlation.","date":"2012","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22373837","citation_count":18,"is_preprint":false},{"pmid":"28827091","id":"PMC_28827091","title":"Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.","date":"2017","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/28827091","citation_count":17,"is_preprint":false},{"pmid":"29723991","id":"PMC_29723991","title":"The Expression Pattern of PLIN2 in Differentiated Adipocytes from Qinchuan Cattle Analysis of Its Protein Structure and Interaction with CGI-58.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29723991","citation_count":17,"is_preprint":false},{"pmid":"31883530","id":"PMC_31883530","title":"A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings.","date":"2019","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/31883530","citation_count":16,"is_preprint":false},{"pmid":"32046372","id":"PMC_32046372","title":"Downregulated ABHD5 Aggravates Insulin Resistance of Trophoblast Cells During Gestational Diabetes Mellitus.","date":"2020","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/32046372","citation_count":16,"is_preprint":false},{"pmid":"25751639","id":"PMC_25751639","title":"Muscle-specific deletion of comparative gene identification-58 (CGI-58) causes muscle steatosis but improves insulin sensitivity in male mice.","date":"2015","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25751639","citation_count":16,"is_preprint":false},{"pmid":"32822232","id":"PMC_32822232","title":"Circular RNA cMras Suppresses the Progression of Lung Adenocarcinoma Through ABHD5/ATGL Axis Using NF-κB Signaling Pathway.","date":"2020","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/32822232","citation_count":15,"is_preprint":false},{"pmid":"39046603","id":"PMC_39046603","title":"Exploring ABHD5 as a Lipid-Related Biomarker in Idiopathic Pulmonary Fibrosis: Integrating Machine Learning, Bioinformatics, and In Vitro Experiments.","date":"2024","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/39046603","citation_count":15,"is_preprint":false},{"pmid":"20528790","id":"PMC_20528790","title":"Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5.","date":"2010","source":"Acta paediatrica (Oslo, Norway : 1992)","url":"https://pubmed.ncbi.nlm.nih.gov/20528790","citation_count":15,"is_preprint":false},{"pmid":"35836935","id":"PMC_35836935","title":"Molecular Modeling of ABHD5 Structure and Ligand Recognition.","date":"2022","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/35836935","citation_count":13,"is_preprint":false},{"pmid":"30936746","id":"PMC_30936746","title":"Oncogenic role of ABHD5 in endometrial cancer.","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/30936746","citation_count":13,"is_preprint":false},{"pmid":"16679288","id":"PMC_16679288","title":"Fat breakdown: a function for CGI-58 (ABHD5) provides a new piece of the puzzle.","date":"2006","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16679288","citation_count":13,"is_preprint":false},{"pmid":"23756328","id":"PMC_23756328","title":"Acitretin-responsive ichthyosis in Chanarin-Dorfman syndrome with a novel mutation in the ABHD5/CGI-58 gene.","date":"2013","source":"Pediatric dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23756328","citation_count":12,"is_preprint":false},{"pmid":"34702801","id":"PMC_34702801","title":"Cardiac-specific CGI-58 deficiency activates the ER stress pathway to promote heart failure in mice.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34702801","citation_count":11,"is_preprint":false},{"pmid":"34791225","id":"PMC_34791225","title":"ABHD5 frameshift deletion in Golden Retrievers with ichthyosis.","date":"2022","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/34791225","citation_count":11,"is_preprint":false},{"pmid":"35586044","id":"PMC_35586044","title":"Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35586044","citation_count":11,"is_preprint":false},{"pmid":"22829614","id":"PMC_22829614","title":"Alternative splicing and developmental and hormonal regulation of porcine comparative gene identification-58 (CGI-58) mRNA.","date":"2012","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/22829614","citation_count":11,"is_preprint":false},{"pmid":"39814233","id":"PMC_39814233","title":"Lipid droplet targeting of the lipase coactivator ABHD5 and the fatty liver disease-causing variant PNPLA3 I148M is required to promote liver steatosis.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39814233","citation_count":10,"is_preprint":false},{"pmid":"26872126","id":"PMC_26872126","title":"Macrophage CGI-58 Attenuates Inflammatory Responsiveness via Promotion of PPARγ Signaling.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26872126","citation_count":10,"is_preprint":false},{"pmid":"20083112","id":"PMC_20083112","title":"Identification of a novel splicing isoform of murine CGI-58.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20083112","citation_count":10,"is_preprint":false},{"pmid":"31118107","id":"PMC_31118107","title":"Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene.","date":"2019","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31118107","citation_count":10,"is_preprint":false},{"pmid":"25121381","id":"PMC_25121381","title":"Chanarin-Dorfman syndrome: clinical report and novel mutation in ABHD5 gene.","date":"2014","source":"Journal of postgraduate medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25121381","citation_count":10,"is_preprint":false},{"pmid":"24492485","id":"PMC_24492485","title":"CGI-58, a key regulator of lipid homeostasis and signaling in plants, also regulates polyamine metabolism.","date":"2014","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/24492485","citation_count":9,"is_preprint":false},{"pmid":"36107452","id":"PMC_36107452","title":"Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice.","date":"2022","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36107452","citation_count":9,"is_preprint":false},{"pmid":"34815115","id":"PMC_34815115","title":"Promotion effect of salt on intramuscular neutral lipid hydrolysis during dry-salting process of porcine (biceps femoris) muscles by inducing phosphorylation of ATGL, HSL and their regulatory proteins of Perilipin1, ABHD5 and G0S2.","date":"2021","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34815115","citation_count":9,"is_preprint":false},{"pmid":"38467717","id":"PMC_38467717","title":"HBB contributes to individualized aconitine-induced cardiotoxicity in mice via interfering with ABHD5/AMPK/HDAC4 axis.","date":"2024","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/38467717","citation_count":9,"is_preprint":false},{"pmid":"29475365","id":"PMC_29475365","title":"A New Case of Chanarin-Dorfman Syndrome with a Novel Deletion in ABHD5 Gene.","date":"2018","source":"Iranian biomedical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29475365","citation_count":8,"is_preprint":false},{"pmid":"35474805","id":"PMC_35474805","title":"Improved Stability of Human CGI-58 Induced by Phosphomimetic S237E Mutation.","date":"2022","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/35474805","citation_count":7,"is_preprint":false},{"pmid":"25178844","id":"PMC_25178844","title":"Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25178844","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50325,"output_tokens":9900,"usd":0.149737},"stage2":{"model":"claude-opus-4-6","input_tokens":13837,"output_tokens":4634,"usd":0.277552},"total_usd":0.427289,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"CGI-58/ABHD5 directly interacts with and activates adipose triglyceride lipase (ATGL), stimulating its triacylglycerol hydrolase activity up to 20-fold. CDS-associated point mutations in CGI-58 abolish this ATGL activation. CGI-58/ATGL coexpression attenuates lipid accumulation in COS-7 cells, and antisense RNA-mediated reduction of CGI-58 in 3T3-L1 adipocytes inhibits TG mobilization.\",\n      \"method\": \"In vitro TG hydrolase assay, Co-IP/interaction studies, gain- and loss-of-function cell models, CDS fibroblast rescue experiments\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted enzymatic activity in vitro, mutagenesis of disease alleles, multiple orthogonal cell-based assays, independently replicated\",\n      \"pmids\": [\"16679289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CGI-58 (ABHD5) belongs to the alpha/beta-hydrolase fold family. Its putative catalytic triad contains asparagine instead of the usual serine residue, distinguishing it from classical esterase/lipase/thioesterase subfamily members. Eight distinct loss-of-function mutations in CGI-58 were identified as the genetic cause of Chanarin-Dorfman Syndrome.\",\n      \"method\": \"Genetic linkage, mutation screening, sequence analysis, bioinformatic domain analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational genetic identification in multiple families, replicated extensively; structural inference from sequence\",\n      \"pmids\": [\"11590543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CGI-58 localizes to lipid droplet surfaces in differentiated 3T3-L1 adipocytes via a direct interaction with perilipin A (PLIN1). This interaction requires the C-terminal sequence of perilipin A (amino acids 382-429). Activation of cAMP-dependent protein kinase (PKA) by isoproterenol disperses CGI-58 from lipid droplets to the cytoplasm, and this shift is reversible.\",\n      \"method\": \"Proteomic analysis of lipid droplets, CGI-58-GFP live imaging, stable cell lines with perilipin mutants, immunoprecipitation, pharmacological PKA activation/inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, imaging, IP, mutagenesis), functionally linked localization\",\n      \"pmids\": [\"15292255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CGI-58 directly interacts with perilipin via yeast two-hybrid and co-localization studies. CDS-associated missense mutations abolish the ability of CGI-58 to be recruited to lipid droplets and weaken binding to perilipin, establishing that loss of this interaction underlies CDS pathogenesis. CGI-58 also interacts with ADRP (perilipin 2).\",\n      \"method\": \"Yeast two-hybrid, GFP-CGI-58 overexpression imaging, CDS mutant analysis in 3T3-L1 and CHO-K1 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid plus cell imaging with disease mutant validation\",\n      \"pmids\": [\"15136565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CGI-58 knockdown causes abnormal lipid droplet accumulation in 3T3-L1 preadipocytes and Hepa1 hepatoma cells, and reduces both basal and PKA-stimulated lipolysis. CGI-58 itself has no intrinsic lipase/esterase activity but enhances ATGL activity. Upon lipolytic stimulation, CGI-58 disperses from lipid droplets to cytosol, and this depends on perilipin phosphorylation which reduces CGI-58 binding.\",\n      \"method\": \"RNAi knockdown, in vitro lipase activity assay, live-cell imaging, coherent anti-Stokes Raman scattering microscopy\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro activity assay (no intrinsic lipase), RNAi with phenotype, live imaging of localization dynamics\",\n      \"pmids\": [\"17308334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Perilipin (PLIN1) binds ABHD5 with high affinity, sequestering it and suppressing its interaction with ATGL to reduce basal lipolysis. PKA-mediated phosphorylation of perilipin on Ser492 or Ser517 rapidly releases ABHD5, allowing direct ABHD5–ATGL interaction primarily on lipid droplets containing perilipin.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC) in live cells, FRET imaging, protein trafficking experiments, PKA activation studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — quantitative live-cell protein interaction assays with site-specific mutagenesis of phosphorylation sites\",\n      \"pmids\": [\"19850935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CGI-58 functions as a coenzyme A-dependent lysophosphatidic acid (LPA) acyltransferase, converting LPA to phosphatidic acid. Recombinant CGI-58 purified from E. coli shows acyl-CoA-dependent acyltransferase activity specifically toward LPA but not other lysophospholipids. This activity is associated with a conserved HXXXXD motif in its C-terminus.\",\n      \"method\": \"Recombinant protein expression in E. coli, in vitro acyltransferase assay, S. cerevisiae overexpression, intrinsic tryptophan fluorescence quenching, radiolabeled fatty acid incorporation in CDS fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified recombinant enzyme with in vitro biochemical assay and functional validation in disease fibroblasts\",\n      \"pmids\": [\"18606822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Recombinant mouse CGI-58 exhibits CoA-dependent acyltransferase activity specifically for lysophosphatidic acid (not other lysophospholipid acceptors), producing phosphatidic acid. It channels fatty acids released from lipolysis into phospholipids in CDS fibroblasts. The enzyme shows preference for arachidonoyl-CoA and oleoyl-CoA and saturation kinetics.\",\n      \"method\": \"Recombinant protein from E. coli, in vitro LPA acyltransferase assay with kinetics, radiolabeled fatty acid tracking in CDS fibroblasts\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified recombinant enzyme, substrate specificity determined, functional rescue in disease cells\",\n      \"pmids\": [\"19801371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CGI-58 knockout mice (Cgi-58−/−) display systemic TG accumulation and severe hepatic steatosis, confirming CGI-58's role in ATGL-mediated TG hydrolysis. Additionally, a lethal skin permeability barrier defect independent of ATGL establishes an ATGL-independent function of CGI-58 in epidermal lipid metabolism, linked to impaired acylceramide synthesis.\",\n      \"method\": \"Global knockout mouse model, lipid analysis, histology, skin barrier assays, lipidomics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with clear dual phenotypic readouts (systemic steatosis + lethal skin barrier defect), establishing two distinct functions\",\n      \"pmids\": [\"20023287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ABHD5 is located in lipid-transporting lamellar granules of differentiating keratinocytes in the granular epidermal layer. CGI-58 knockdown in cultured keratinocytes reduced expression of differentiation markers, establishing a functional role in keratinocyte differentiation and lamellar granule lipid metabolism.\",\n      \"method\": \"Immunoelectron microscopy, anti-CGI-58 antibody immunostaining, siRNA knockdown in human keratinocytes, 3D organotypic cultures\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — subcellular localization by immunoelectron microscopy linked to functional consequence via KD\",\n      \"pmids\": [\"18832586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Mldp (LSDP5/PLIN5) binds ABHD5 and directs it to lipid droplets; this interaction is required for Atgl activation at PLIN5-containing lipid droplets. An ABHD5 mutant (E262K) with greatly reduced Mldp binding cannot prevent lipid droplet accumulation in cells expressing Mldp despite targeting of Atgl.\",\n      \"method\": \"Protein-protein interaction assays in transfected fibroblasts, cardiac muscle fiber microdissection imaging, ABHD5 E262K mutagenesis, lipid droplet morphology assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional readout, in situ interaction analysis\",\n      \"pmids\": [\"19064991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The N-terminal region (amino acids 1–30) of CGI-58 contains a tryptophan-rich stretch that is essential for lipid droplet binding and ATGL activation. N-terminally truncated CGI-58 localizes to cytoplasm and fails to activate ATGL, demonstrating that correct LD localization is required for ATGL-activating function.\",\n      \"method\": \"3D homology modeling, 1H NMR with DPC micelles, GFP-fusion localization in cultured cells, N-terminal deletion mutagenesis, ATGL activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — NMR structural data plus mutagenesis linked to functional loss of ATGL activation\",\n      \"pmids\": [\"20164531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"G0S2 binds to ATGL independently of CGI-58 and its activity state, and cells co-expressing G0S2 and CGI-58+ATGL cannot stimulate lipid droplet turnover, indicating that CGI-58 and G0S2 regulate ATGL via non-competing mechanisms.\",\n      \"method\": \"Overexpression studies in cells, Co-IP, lipid droplet morphology assays\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and cell-based assays, single lab, functional inference\",\n      \"pmids\": [\"20676045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The C-terminus of PLIN1 sequesters ABHD5 and inhibits basal ATGL activity. Human frame-shift mutations (Leu404fs, Val398fs) in PLIN1 fail to bind ABHD5 as shown by bimolecular fluorescence complementation, leading to constitutive ABHD5-mediated ATGL coactivation and increased basal lipolysis. siRNA knockdown of ABHD5 or ATGL reversed this increased lipolysis.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC), siRNA knockdown of ABHD5/ATGL in stably transfected preadipocytes, lipolysis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human disease variant analysis, BiFC protein interaction, epistatic rescue by KD\",\n      \"pmids\": [\"21757733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The minimal active domain of ATGL (extending to Leu254, beyond the patatin domain to Leu178) can still be activated by CGI-58 and inhibited by G0S2, establishing that the interaction surfaces for both regulators reside within this minimal domain.\",\n      \"method\": \"Domain truncation mutagenesis, in vitro lipase activity assay, protein-protein interaction studies, 3D homology modeling\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro activity assays with deletion mutants and structural modeling\",\n      \"pmids\": [\"22039468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CGI-58/ABHD5 Ser239 is phosphorylated by protein kinase A (PKA) in vivo. PKA-mediated phosphorylation of CGI-58 at Ser239 is required for its dispersion from perilipin 1A-coated lipid droplets upon lipolytic stimulation, thereby increasing CGI-58 availability for ATGL coactivation. Phosphorylation does not alter ATGL coactivation activity per se.\",\n      \"method\": \"Phosphoamino acid analysis, mass spectrometry, immunoblotting of recombinant and endogenous CGI-58, phosphomimetic/alanine mutant localization studies in cells, in vitro ATGL coactivation assay\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — MS identification of phosphosite, mutagenesis, functional localization assays\",\n      \"pmids\": [\"25421061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ABHD5 is the direct target of synthetic ligands and endogenous long-chain acyl-CoA ligands that regulate ABHD5–perilipin interactions. Ligand binding to ABHD5 releases it from PLIN1 or PLIN5 without PKA activation, directly activating adipocyte and muscle lipolysis. Affinity probe labeling demonstrated ABHD5 as the direct ligand target.\",\n      \"method\": \"Molecular imaging, affinity probe labeling, synthetic ligand functional assays in adipocytes and muscle cells, fluorescence complementation\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct affinity labeling demonstrating ABHD5 as ligand target, multiple orthogonal functional assays\",\n      \"pmids\": [\"26411340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NMR structure of the CGI-58 N-terminal tryptophan-rich peptide (residues 10–31) bound to DPC micelles reveals two anchor arms: a left arm (Trp21/Trp25 plus adjacent leucines) and a right arm (Trp29). Simultaneous tryptophan-to-alanine mutations in both arms abolish LD localization and ATGL activation, whereas single-arm mutations do not.\",\n      \"method\": \"Solution-state NMR structure of LD-anchor peptide in DPC micelles, tryptophan-alanine mutagenesis, subcellular localization assays, ATGL activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional mutagenesis validation\",\n      \"pmids\": [\"26350461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Perilipins 2 and 3 lack the C-terminal carboxy-terminal domain of perilipin 1 that binds and stabilizes ABHD5. This C-terminal domain of PLIN1 retards ABHD5 proteasomal degradation. Chimeric PLIN2 or PLIN3 fused with the PLIN1 C-terminus suppress basal lipolysis more effectively by stabilizing ABHD5. Knockdown of PLIN1 in adipocytes reduces ABHD5 expression and LD localization, increasing basal lipolysis.\",\n      \"method\": \"BiFC, chimeric protein construction, PLIN1 siRNA knockdown, ABHD5 protein stability assays (proteasome inhibition)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including chimeric protein rescue and proteasome experiments\",\n      \"pmids\": [\"24927580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Two conserved ABHD5 residues (R299 and G328) are specifically required for ATGL lipase activation. Introducing these residues into the ABHD4 paralog (ABHD4 N303R/S332G) conferred ATGL activation ability, and corresponding ABHD5 mutations (R299N, G328S) selectively disrupted lipolysis without affecting ATGL LD translocation or ABHD5 interactions with perilipins/ligands. Structural modeling places these residues on a novel functional surface.\",\n      \"method\": \"Comparative evolutionary analysis, structural modeling, gain-of-function ABHD4 mutagenesis in Cos7 cells/brown adipocytes/artificial lipid droplets, loss-of-function ABHD5 mutagenesis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal gain- and loss-of-function mutagenesis with multiple functional readouts\",\n      \"pmids\": [\"28211464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PNPLA3 (wild-type and 148M variant) directly interacts with CGI-58 and requires CGI-58 for its localization to hepatic lipid droplets. PNPLA3 inhibits ATGL activity by competing for CGI-58, and PNPLA3(148M) promotes hepatic steatosis in a CGI-58-dependent manner. Direct PNPLA3–CGI-58 interaction was demonstrated by Co-IP and pulldown with purified proteins.\",\n      \"method\": \"Co-IP in mouse liver, in vitro pulldown with purified proteins, liver-specific Cgi-58 KO mice, HuH-7 cell overexpression, hepatic TG measurement\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct interaction confirmed with purified proteins, genetic epistasis in vivo (Cgi-58 KO rescues PNPLA3-148M steatosis)\",\n      \"pmids\": [\"30802989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ABHD5 functions as a serine protease that cleaves HDAC4 in cardiomyocytes, generating an N-terminal HDAC4 polypeptide (HDAC4-NT). This proteolytic activity inhibits MEF2-dependent gene expression and controls glucose handling in the heart. ABHD5 deficiency leads to loss of HDAC4-NT generation and heart failure, independent of lipid accumulation.\",\n      \"method\": \"In vitro and in vivo serine protease assay, cardiac-specific gene therapy (HDAC4-NT), transgenic ABHD5 mouse model, pressure-overload heart failure model, analysis of failing human hearts\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — novel enzymatic function demonstrated in vitro and in vivo with rescue experiment, functional dissociation from lipid phenotype\",\n      \"pmids\": [\"31742248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ABHD5 directly interacts with PNPLA1 and recruits it to lipid droplets, stimulating PNPLA1-mediated esterification of ω-hydroxy ceramides with linoleic acid to produce ω-O-acylceramide (acylceramide). CDS-associated ABHD5 point mutations fail to stimulate PNPLA1-mediated acylceramide biosynthesis.\",\n      \"method\": \"Acylceramide-producing cell system, immunofluorescence microscopy, ABHD5–PNPLA1 interaction assays, CDS mutant analysis\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — interaction and functional activation demonstrated with disease mutant validation\",\n      \"pmids\": [\"30361410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ABHD5 enhances PNPLA1-catalyzed acylceramide production by promoting PNPLA1 localization to lipid droplet membranes. Co-expression of ABHD5 with PNPLA1 transforms dispersed PNPLA1 distribution into lipid droplet-associated localization, and ABHD5 CDS mutations reduce this activity.\",\n      \"method\": \"Immunofluorescent microscopy, immunoelectron microscopy, cell-based acylceramide production assay, ABHD5 CDS mutant analysis\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic localization with immunoelectron microscopy and functional readout with disease mutants\",\n      \"pmids\": [\"30527376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ABHD5 directly competes with CASP3 for binding to cleavage sites of BECN1 (Beclin 1), thereby preventing BECN1 cleavage by CASP3. ABHD5 deficiency allows CASP3-mediated BECN1 cleavage, impairing autophagic flux and promoting genomic instability and tumorigenesis in colorectal cancer, independent of PNPLA2/ATGL.\",\n      \"method\": \"Co-IP, competition binding assays, autophagic flux assays, ABHD5 KO in CRC cells, clinical tissue correlation\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP and competition binding with functional autophagy readout, single lab\",\n      \"pmids\": [\"27559856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ABHD5 deficiency in macrophages activates mitochondrial ROS production due to impaired PPARγ signaling, which activates the NLRP3 inflammasome, leading to proinflammatory cytokine secretion. Macrophage-specific CGI-58 KO mice show exacerbated HFD-induced insulin resistance and inflammation reversible by anti-ROS treatment or NLRP3 silencing.\",\n      \"method\": \"Macrophage-specific CGI-58 KO mice, anti-ROS treatment, NLRP3 siRNA knockdown, co-culture fat slice assay, mitochondrial function assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple mechanistic interventions (ROS scavenging, NLRP3 KD) confirming pathway\",\n      \"pmids\": [\"24703845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ABHD5 suppresses spermidine synthase (SRM)-dependent spermidine production in macrophages by inhibiting ROS-dependent expression of C/EBPε, a transcription factor that activates srm gene transcription. Macrophage-specific ABHD5 transgene promotes colorectal cancer growth that is prevented by an additional SRM transgene.\",\n      \"method\": \"In vitro macrophage assays, mouse macrophage-specific transgenic models, SRM transgene rescue experiment, C/EBPε and ROS pathway analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis rescue (SRM transgene prevents ABHD5-transgene-driven tumor growth), pathway mechanistically defined\",\n      \"pmids\": [\"27189574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ABHD5 deficiency in macrophages promotes NFκB p65-dependent matrix metalloproteinase (MMP) production independently of its triglyceride metabolic function, as neither triglycerides nor ABHD5-regulated metabolites affected cancer cell migration.\",\n      \"method\": \"Macrophage ABHD5 KO xenograft and genetic cancer models, in vitro migration assays, NFκB pathway analysis, metabolite measurements\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional dissection from metabolic role, NFκB pathway shown, but limited mechanistic depth on how ABHD5 controls NFκB\",\n      \"pmids\": [\"31439546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss of ABHD5 in colon cancer cells induces epithelial-mesenchymal transition by suppressing the AMPKα-p53 pathway, which promotes aerobic glycolysis (Warburg effect). Intestine-specific knockout of Abhd5 in ApcMin/+ mice robustly increases tumorigenesis and malignant transformation.\",\n      \"method\": \"RNAi silencing, intestine-specific KO in ApcMin/+ mice, AMPK/p53 pathway analysis, Warburg effect measurement\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with mechanistic pathway (AMPK-p53) identified and validated\",\n      \"pmids\": [\"25482557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ABHD5 interacts with DPY30 (core subunit of SET1A methyltransferase complex) in the cytoplasm, inhibiting its nuclear translocation and SET1A-mediated methylation of YAP and histone H3. ABHD5 loss allows DPY30 nuclear accumulation, promoting YAP transcriptional activity and c-Met-driven cancer stemness.\",\n      \"method\": \"Co-IP, subcellular fractionation, DPY30 localization imaging, SET1A activity assays, ChIP, CRC cell functional assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction demonstrated, nuclear translocation mechanistically linked to epigenetic and transcriptional consequences\",\n      \"pmids\": [\"34795238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CGI-58 functions as a lysophosphatidylglycerol acyltransferase, catalyzing reacylation of lysophosphatidylglycerol to phosphatidylglycerol (PG) in an acyl-CoA-dependent manner. Overexpression and knockdown of CGI-58 adversely affect endogenous PG levels in C2C12 cells, and CGI-58 regulates autophagy/mitophagy through effects on cardiolipin synthesis.\",\n      \"method\": \"Recombinant CGI-58 from Sf9 insect cells and mammalian cells, in vitro acyltransferase assay, PG measurement, autophagy/mitophagy assays in C2C12 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–3 — in vitro enzymatic activity shown with purified protein, cellular functional readouts; conflicting with LPA acyltransferase specificity in prior studies\",\n      \"pmids\": [\"25315780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ABHD5 cooperates specifically with ATGL (not ABHD4) to mobilize lipid droplet triglycerides for hepatitis C virus assembly. ABHD5 residues critical for ATGL activation are required for pro-viral lipolytic function. Grafting these ABHD5 residues onto ABHD4 restored ATGL interaction and pro-viral function; mutating the predicted ABHD5-ATGL interface ablated both lipolysis and HCV assembly support.\",\n      \"method\": \"ABHD4/ABHD5 chimeric mutagenesis, protein interaction assays, lipid droplet lipolysis assays, HCV production assays, ATGL KD/modulation\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — gain/loss-of-function chimeric protein approach with multiple functional readouts, mechanistically defines interaction interface\",\n      \"pmids\": [\"32542055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Lipid droplet targeting of ABHD5 and PNPLA3 I148M is required for their direct interaction. PNPLA3 I148M has greater association with ABHD5 than WT PNPLA3 (by fluorescence cross-correlation spectroscopy), and the C-terminus of PNPLA3 is sufficient for LD targeting and ABHD5 interaction. PNPLA3 I148M LD targeting is required to promote steatosis in vitro and in liver.\",\n      \"method\": \"Fluorescence cross-correlation spectroscopy (FCCS), molecular modeling, C-terminal domain truncation/chimeric proteins, in vitro steatosis assay, in vivo liver steatosis model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — quantitative in-cell FCCS protein interaction, mutagenesis, and in vivo functional validation\",\n      \"pmids\": [\"39814233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ABHD5-mediated lipolysis inhibits mTORC1 signaling in prostate cancer cells by elevating intracellular AMP content and activating AMPK. This creates an energy-consuming futile cycle between TG hydrolysis and resynthesis (requiring DGAT1/DGAT2), leading to AMPK activation, mTORC1 inhibition, and cancer cell growth arrest.\",\n      \"method\": \"ABHD5 overexpression and pharmacological lipolysis activation, transcriptomic profiling, AMPK/mTORC1 pathway analysis, DGAT1/2 inhibition, AMP measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pathway interventions supporting mechanism, single lab\",\n      \"pmids\": [\"33219129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ABHD5 associates with hepatic lipid droplets and is required for HCV-driven lipid droplet consumption; Chanarin-Dorfman syndrome ABHD5 mutants are mislocalized and unable to support HCV production or LD lipolysis. A novel tribasic motif in ABHD5 determines both lipolytic and pro-viral properties without affecting LD localization.\",\n      \"method\": \"siRNA screen, ABHD5 mutant localization studies, lipid droplet hydrolysis assays, HCV assembly/release assays, tribasic motif mutagenesis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis with multiple functional readouts, disease mutant validation\",\n      \"pmids\": [\"27124600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CGI-58 knockdown sequesters diacylglycerols (DAG) in lipid droplets/ER rather than the plasma membrane, preventing PKCε translocation to the plasma membrane and thereby protecting against DAG-mediated hepatic insulin resistance despite hepatic steatosis.\",\n      \"method\": \"Antisense oligonucleotide KD, hyperinsulinemic-euglycemic clamp, subcellular DAG fractionation, PKCε localization analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo clamp studies with subcellular fractionation mechanistically linking DAG compartmentalization to PKCε and insulin resistance\",\n      \"pmids\": [\"23302688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATGL/CGI-58 are expressed in intestinal enterocytes and are critical for hydrolysis of a specific lipid droplet pool derived from basolateral (blood) lipid re-uptake, but not for chylomicron synthesis from dietary lipids. Intestine-specific ATGL/CGI-58 double KO mice show massive cLD accumulation independent of dietary lipids.\",\n      \"method\": \"Intestine-specific double KO mouse model, dietary lipid absorption assays, lipid droplet pool characterization\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic double KO with defined physiological readout establishing specific LD pool assignment\",\n      \"pmids\": [\"31412256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CGI-58 regulates hepatic TG metabolism and diacylglycerol levels in an ATGL-independent manner; CGI-58 knockdown causes hepatic steatosis in the genetic absence of ATGL. CGI-58 also regulates hepatic inflammation independently of ATGL.\",\n      \"method\": \"Direct comparison of single vs. double CGI-58/ATGL knockdown mice (ASO), hepatic lipid and inflammation measurements\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo (KO/KD comparison) establishing ATGL-independent hepatic function\",\n      \"pmids\": [\"27396333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A murine CGI-58 short splicing isoform (mCGI-58S), lacking exons 2 and 3, localizes to cytoplasm (not LDs), cannot activate ATGL, but retains lysophosphatidic acid acyltransferase activity. This establishes functional dissociation between LD/ATGL activation and LPA acyltransferase activities.\",\n      \"method\": \"cDNA cloning, GFP-fusion localization, ATGL activation assay, LPA acyltransferase assay, LD turnover assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis/isoform comparison with multiple functional assays, single lab\",\n      \"pmids\": [\"20083112\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABHD5/CGI-58 is a lipid droplet-associated co-activator protein (lacking intrinsic lipase activity) that stimulates ATGL-mediated triacylglycerol hydrolysis up to 20-fold via direct protein–protein interaction; its activity is regulated by sequestration on lipid droplets through high-affinity binding to perilipin proteins (PLIN1, PLIN5), which is relieved by PKA-mediated phosphorylation of both perilipin and ABHD5-Ser239 upon adrenergic stimulation; beyond ATGL coactivation, ABHD5 also acts as an LPA acyltransferase, a coactivator of PNPLA1 for acylceramide biosynthesis (critical for skin barrier), a serine protease cleaving HDAC4 (cardioprotective), a direct PNPLA3-I148M interaction partner sequestering ABHD5 on hepatic lipid droplets to promote steatosis, a competitor of CASP3 for BECN1 cleavage sites (regulating autophagy), and an inhibitor of DPY30/SET1A nuclear methyltransferase activity (regulating cancer stemness), collectively establishing ABHD5 as a multifunctional lipid droplet scaffold protein that coordinates lipolysis, lipid signaling, epidermal barrier formation, cardiac glucose metabolism, and inflammatory signaling across multiple tissues.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ABHD5 (CGI-58) is a multifunctional lipid droplet scaffold protein that coordinates triacylglycerol hydrolysis, phospholipid remodeling, epidermal barrier formation, and signaling across adipose, hepatic, cardiac, and immune tissues. ABHD5 lacks intrinsic lipase activity due to an asparagine substitution in its catalytic triad but activates ATGL-mediated triacylglycerol hydrolysis up to 20-fold through direct protein–protein interaction requiring residues R299 and G328; its availability is governed by sequestration on lipid droplets via high-affinity binding to perilipin 1 (C-terminal domain) and PLIN5, which is relieved by PKA-mediated phosphorylation of both perilipin and ABHD5-Ser239 or by direct binding of long-chain acyl-CoA ligands [PMID:16679289, PMID:19850935, PMID:25421061, PMID:26411340, PMID:28211464]. Beyond ATGL coactivation, ABHD5 possesses intrinsic lysophosphatidic acid acyltransferase activity, coactivates PNPLA1 for acylceramide biosynthesis essential for the epidermal permeability barrier, acts as a serine protease cleaving HDAC4 to regulate cardiac glucose metabolism, sequesters PNPLA3-I148M on hepatic lipid droplets to promote steatosis, protects BECN1 from CASP3 cleavage to maintain autophagic flux, and retains DPY30 in the cytoplasm to inhibit SET1A-mediated histone methylation [PMID:18606822, PMID:30361410, PMID:31742248, PMID:30802989, PMID:27559856, PMID:34795238]. Loss-of-function mutations in ABHD5 cause Chanarin–Dorfman syndrome, characterized by systemic triglyceride accumulation, ichthyosis from defective acylceramide synthesis, and hepatic steatosis [PMID:11590543, PMID:20023287].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying ABHD5 as the gene mutated in Chanarin–Dorfman syndrome established that this α/β-hydrolase-fold protein with an atypical catalytic triad (Asn replacing Ser) is essential for neutral lipid metabolism in humans.\",\n      \"evidence\": \"Genetic linkage and mutation screening in CDS families combined with bioinformatic domain analysis\",\n      \"pmids\": [\"11590543\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No enzymatic or coactivator function yet demonstrated\", \"Mechanistic basis of lipid accumulation unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that ABHD5 localizes to lipid droplets via direct binding to perilipin 1's C-terminus and is released upon PKA activation established the regulated-sequestration model for ABHD5 availability.\",\n      \"evidence\": \"Lipid droplet proteomics, GFP-CGI-58 live imaging, yeast two-hybrid, perilipin mutant analysis in 3T3-L1 adipocytes\",\n      \"pmids\": [\"15292255\", \"15136565\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target enzyme for ABHD5 coactivation not yet identified\", \"Mechanism of PKA-mediated release not molecularly defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The discovery that ABHD5 directly binds and activates ATGL up to 20-fold—and that CDS mutations abolish this activation—identified the central enzymatic target and mechanistically explained systemic triglyceride accumulation in CDS.\",\n      \"evidence\": \"In vitro TG hydrolase assay with recombinant proteins, Co-IP, gain/loss-of-function in COS-7 and 3T3-L1 cells, CDS fibroblast rescue\",\n      \"pmids\": [\"16679289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interaction surface between ABHD5 and ATGL undefined\", \"ATGL-independent functions not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of intrinsic LPA acyltransferase activity in purified recombinant ABHD5 revealed that the protein possesses its own catalytic function beyond ATGL coactivation, converting LPA to phosphatidic acid via a conserved HXXXXD motif.\",\n      \"evidence\": \"Recombinant ABHD5 from E. coli, in vitro acyltransferase assay with substrate specificity, radiolabeled fatty acid incorporation in CDS fibroblasts\",\n      \"pmids\": [\"18606822\", \"19801371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological significance of LPA acyltransferase activity in vivo not established\", \"Relationship between acyltransferase and ATGL-coactivation functions unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The CGI-58 knockout mouse revealed two separable functions: systemic TG accumulation (ATGL-dependent) and a lethal skin barrier defect from impaired acylceramide synthesis (ATGL-independent), establishing ABHD5 as a bifunctional protein.\",\n      \"evidence\": \"Global Cgi-58 knockout mouse with lipid analysis, histology, and skin barrier assays\",\n      \"pmids\": [\"20023287\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partner mediating acylceramide synthesis unknown at this stage\", \"Relative contributions of ATGL activation vs. acyltransferase activity to each phenotype unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Quantitative live-cell BiFC and FRET resolved the sequential mechanism: PLIN1 sequesters ABHD5 under basal conditions, and PKA phosphorylation of specific perilipin serines (Ser492/Ser517) releases ABHD5 to interact with ATGL on lipid droplets.\",\n      \"evidence\": \"BiFC and FRET imaging in live cells with perilipin phosphosite mutants, PKA activation\",\n      \"pmids\": [\"19850935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ABHD5 itself is phosphorylated during this process was not yet known\", \"Stoichiometry of the ABHD5–PLIN1–ATGL complex undefined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"NMR and mutagenesis of the N-terminal tryptophan-rich region (residues 10–31) showed that two amphipathic anchor arms mediate lipid droplet binding, which is prerequisite for ATGL activation—functionally separating LD targeting from catalytic domains.\",\n      \"evidence\": \"Solution NMR in DPC micelles, tryptophan-to-alanine mutagenesis, subcellular localization and ATGL activation assays\",\n      \"pmids\": [\"20164531\", \"26350461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length ABHD5 structure unavailable\", \"How the N-terminal anchor cooperates with perilipin binding unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of PKA phosphorylation at ABHD5-Ser239 showed that ABHD5 itself is directly regulated post-translationally: phosphorylation promotes its dispersion from PLIN1-coated droplets without altering intrinsic ATGL coactivation capacity.\",\n      \"evidence\": \"Mass spectrometry, phosphomimetic/alanine mutant localization studies, in vitro ATGL coactivation assay\",\n      \"pmids\": [\"25421061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Other phosphorylation sites or post-translational modifications not systematically surveyed\", \"Kinetic relationship between perilipin and ABHD5 phosphorylation events unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"PLIN1's C-terminal domain was shown to stabilize ABHD5 against proteasomal degradation, explaining why perilipins 2 and 3 cannot fully substitute for PLIN1 in restraining basal lipolysis—and why PLIN1 frameshift mutations cause constitutive lipolysis.\",\n      \"evidence\": \"BiFC, chimeric perilipin constructs, PLIN1 siRNA, proteasome inhibition assays, PLIN1 frameshift mutation analysis\",\n      \"pmids\": [\"24927580\", \"21757733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PLIN1 C-terminus–ABHD5 interaction unknown\", \"Whether ABHD5 degradation differs across tissues not examined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that endogenous long-chain acyl-CoAs and synthetic ligands directly bind ABHD5 and release it from perilipins without PKA activation revealed a second, hormone-independent mechanism for controlling lipolysis.\",\n      \"evidence\": \"Affinity probe labeling of ABHD5, synthetic ligand functional assays in adipocytes and muscle cells, fluorescence complementation\",\n      \"pmids\": [\"26411340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding site on ABHD5 for acyl-CoA ligands not structurally defined\", \"Physiological contexts where ligand-driven (vs. PKA-driven) release dominates remain unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Reciprocal gain- and loss-of-function mutagenesis identified R299 and G328 as the two residues that specifically confer ATGL coactivation, defining a discrete functional surface distinct from LD targeting and perilipin/ligand-binding regions.\",\n      \"evidence\": \"ABHD4→ABHD5 chimeric mutagenesis in Cos7 cells, brown adipocytes, and artificial lipid droplets with multiple readouts\",\n      \"pmids\": [\"28211464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural visualization of the ABHD5–ATGL interface lacking\", \"Whether these residues participate in activation of other PNPLA family members untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that ABHD5 recruits PNPLA1 to lipid droplets and stimulates its ω-O-acylceramide biosynthesis—abolished by CDS mutations—identified the molecular mechanism underlying the ATGL-independent skin barrier defect observed in CGI-58 knockout mice.\",\n      \"evidence\": \"Immunofluorescence, immunoelectron microscopy, cell-based acylceramide production assays, CDS mutant analysis\",\n      \"pmids\": [\"30361410\", \"30527376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ABHD5 allosterically activates PNPLA1 or only promotes its LD recruitment is unresolved\", \"Therapeutic rescue of CDS skin phenotype by PNPLA1 modulation not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that PNPLA3 (especially the I148M steatosis variant) directly binds and sequesters ABHD5 on hepatic lipid droplets—competing with ATGL for ABHD5—mechanistically explained how PNPLA3-I148M promotes hepatic steatosis through ABHD5 titration.\",\n      \"evidence\": \"Co-IP in liver, in vitro pulldown with purified proteins, liver-specific Cgi-58 KO epistasis, FCCS quantification of binding affinities, domain mapping\",\n      \"pmids\": [\"30802989\", \"39814233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of differential PNPLA3 WT vs. I148M affinity for ABHD5 unknown\", \"Whether therapeutic ABHD5 ligands can overcome PNPLA3-I148M sequestration untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of ABHD5 as a serine protease that cleaves HDAC4 in cardiomyocytes—generating a cardioprotective N-terminal fragment that inhibits MEF2-dependent transcription—revealed an entirely new enzymatic activity independent of lipid metabolism.\",\n      \"evidence\": \"In vitro and in vivo protease assays, cardiac-specific gene therapy rescue, pressure-overload heart failure model, analysis of failing human hearts\",\n      \"pmids\": [\"31742248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic mechanism and active site for protease activity not structurally characterized\", \"Whether other substrates beyond HDAC4 are cleaved unknown\", \"Independent replication of protease activity awaited\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"ABHD5 was shown to protect BECN1 from CASP3-mediated cleavage by directly competing for the cleavage site, maintaining autophagic flux—loss of ABHD5 impairs autophagy and promotes colorectal tumorigenesis independently of ATGL.\",\n      \"evidence\": \"Co-IP, competition binding assays, autophagic flux assays, ABHD5 KO in CRC cells\",\n      \"pmids\": [\"27559856\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of ABHD5–BECN1 interaction undefined\", \"Single-lab finding not yet independently confirmed\", \"Whether ABHD5 protease activity contributes to BECN1 protection untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Establishing that CGI-58 regulates hepatic TG and DAG levels independently of ATGL (by comparing single vs. double KD mice) showed that ABHD5 has ATGL-independent lipid metabolic functions in liver, possibly through its acyltransferase activity or activation of other PNPLA enzymes.\",\n      \"evidence\": \"Direct comparison of single vs. double CGI-58/ATGL knockdown mice by ASO, hepatic lipid and inflammation measurements\",\n      \"pmids\": [\"27396333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise enzyme(s) mediating ATGL-independent hepatic TG hydrolysis not identified\", \"Contribution of LPA acyltransferase vs. other activities unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery that ABHD5 binds DPY30 in the cytoplasm and prevents its nuclear translocation—thereby inhibiting SET1A-mediated methylation of YAP and histone H3—linked ABHD5 to epigenetic regulation and cancer stemness control.\",\n      \"evidence\": \"Co-IP, subcellular fractionation, DPY30 localization imaging, SET1A activity assays, ChIP, CRC cell functional assays\",\n      \"pmids\": [\"34795238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface between ABHD5 and DPY30 not structurally characterized\", \"Whether this mechanism operates in normal (non-cancer) tissues unknown\", \"Relationship between DPY30 sequestration and ABHD5's lipid droplet functions not explored\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full-length atomic structure of ABHD5 is lacking, leaving the spatial relationships among the N-terminal LD anchor, the ATGL-activating surface (R299/G328), the acyltransferase HXXXXD motif, the ligand-binding pocket, the perilipin-binding region, and the putative protease active site unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of full-length ABHD5\", \"How a single protein accommodates ATGL coactivation, LPA acyltransferase, and serine protease activities structurally unresolved\", \"Comprehensive substrate profiling for the protease activity needed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [6, 7, 30, 38]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5, 13, 19]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [11, 16, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [2, 3, 4, 9, 11, 17, 34]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 15, 38]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 5, 6, 7, 8, 15, 16, 19, 35, 36, 37]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [25, 28, 29, 33]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [24, 30]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [29]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [25, 26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PNPLA2\",\n      \"PLIN1\",\n      \"PLIN5\",\n      \"PNPLA1\",\n      \"PNPLA3\",\n      \"HDAC4\",\n      \"DPY30\",\n      \"BECN1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}